Cannabis Vaping & Edibles

On This Page

The Potency Revolution

The cannabis market has undergone a fundamental transformation over the past two decades. What was once a relatively low-potency plant consumed primarily by smoking has evolved into a diverse product category spanning flower, concentrates, edibles, tinctures, topicals, beverages, and vape cartridges -- many of which deliver THC at concentrations that would have been pharmacologically impossible in previous eras.

In 1995, the average THC content of cannabis flower seized by the DEA was approximately 3.96%. By 2022, the average THC content of commercially available flower had risen to over 16%, with premium strains regularly testing at 25-30%. But flower is no longer the dominant product category in many legal markets. Vape cartridges, which now account for a growing share of cannabis sales, typically contain 60-90% THC. Concentrates like shatter, wax, and live resin reach 60-95% THC. This represents a 15-25 fold increase in THC exposure per use compared to the cannabis of 30 years ago.

This potency escalation was not driven by consumer demand for specific THC percentages -- it was driven by market competition, agricultural selection for maximum THC yield, and a regulatory environment that treats cannabis as a single substance regardless of potency. Unlike alcohol, where beer (5% ABV), wine (12% ABV), and spirits (40% ABV) are regulated, taxed, and marketed differently, cannabis products spanning 15% to 95% THC are treated as essentially the same product in most state regulatory frameworks. This is a profound regulatory failure with direct public health consequences.

THC Content Comparisons by Product Type

The Delayed Onset Problem: Why Edibles Cause Overconsumption

Cannabis edibles present a unique pharmacological challenge that makes them disproportionately responsible for adverse events and emergency department visits. The core problem is the gap between consumption and effect.

When cannabis is smoked or vaped, THC enters the bloodstream through the lungs and reaches the brain within seconds to minutes. This rapid feedback loop allows the user to titrate their dose -- they feel the effects quickly and can stop consuming. Edibles work entirely differently. When THC is ingested, it must pass through the digestive system and be metabolized by the liver before producing psychoactive effects. This process takes anywhere from 30 minutes to 2 hours, depending on the person's metabolism, stomach contents, body composition, and the specific product.

During this delay, inexperienced users -- and even experienced ones -- frequently conclude that the initial dose "isn't working" and consume more. By the time the full effects of the combined doses hit, the user has consumed far more THC than intended. This pattern, known as overconsumption or "greening out," is the single most common cause of cannabis-related emergency department visits in legalized states.

The 11-Hydroxy-THC Factor

Edibles also produce a qualitatively different pharmacological experience than inhaled cannabis. When THC passes through the liver, a significant portion is converted into 11-hydroxy-THC (11-OH-THC), a metabolite that crosses the blood-brain barrier more efficiently than THC itself and is estimated to be 2-3 times more psychoactive. This is why edible experiences are often described as more intense, longer-lasting, and more likely to produce anxiety, paranoia, and psychotic symptoms than smoking the same total amount of THC. The effects of edibles can last 6-10 hours, compared to 1-3 hours for smoked or vaped cannabis.

Vaping-Specific Risks: EVALI, Additives, and Youth Appeal

EVALI: A Case Study in Unregulated Products

In 2019, an outbreak of severe lung injuries linked to vaping products -- dubbed EVALI (E-cigarette or Vaping Product Use-Associated Lung Injury) -- caused 2,807 hospitalizations and 68 deaths across the United States (CDC). Investigation identified vitamin E acetate, a thickening agent used in many illicit THC vape cartridges, as the primary cause. While cases declined after public health warnings and the identification of the causative agent, the outbreak exposed the fundamental safety risks of inhaling vaporized substances with unknown additives.

EVALI was concentrated in THC vape products, not nicotine-only products. The outbreak disproportionately affected young people: the median age of EVALI patients was 24, and 15% were under 18. The lesson of EVALI is that cannabis vaping introduces respiratory risks that do not exist with other consumption methods, and these risks are amplified by an illicit market that operates alongside -- and often undercuts -- the regulated market.

Unknown Additives and Long-Term Risks

Even in regulated markets, cannabis vape products may contain thinning agents, flavoring compounds, and other additives whose long-term inhalation effects have not been studied. Propylene glycol and vegetable glycerin -- common carrier liquids in vape products -- produce formaldehyde and acetaldehyde when heated to high temperatures. Heavy metal exposure from vape device heating elements is another documented concern. The long-term respiratory consequences of daily cannabis vaping will not be fully understood for decades, because the products have not existed long enough for longitudinal data.

Youth Appeal and Concealment

Cannabis vape devices are particularly appealing to young people for several reasons: they produce minimal odor (making use easier to conceal from parents and teachers), they are small and resemble common electronics like USB drives or pens, they deliver high THC concentrations efficiently, and they are perceived as safer than smoking. The concealment factor is especially concerning because it allows teens to use cannabis in places and situations where smoking would be immediately detected -- including at school, in their bedrooms, and in cars. For parents, see Teen Cannabis Use.

Why High Potency Matters for Mental Health

The relationship between cannabis potency and mental health outcomes is not linear -- it is exponential. Research consistently demonstrates that as THC concentrations increase, the risks to mental health increase disproportionately. This is particularly true for psychosis, anxiety disorders, and the development of cannabis use disorder.

The Dose-Response Psychosis Relationship

The landmark EU-GEI study (Di Forti et al., Lancet Psychiatry, 2019) examined the relationship between cannabis potency and first-episode psychosis across 11 sites in Europe and Brazil. The findings were striking: daily use of high-potency cannabis (>10% THC) was associated with 5 times the odds of a first-episode psychotic disorder compared to never-users. In cities where high-potency cannabis dominated the market (Amsterdam, London), the population-attributable fraction of psychosis due to cannabis was estimated at 30-50% -- meaning that eliminating high-potency cannabis use could theoretically prevent nearly half of new psychosis cases in these cities.

This dose-response relationship has profound implications for the high-potency products now dominating the U.S. market. If cannabis products with >10% THC carry a 5x psychosis risk, what is the risk profile of products containing 60-90% THC? The answer is that we do not yet have precise data at these extreme concentrations, because they did not exist when the major epidemiological studies were conducted. The available evidence suggests the risk is substantial and likely exceeds what current guidelines anticipate. For detailed coverage, see Cannabis and Psychosis.

Accelerated Dependence

Higher THC concentrations accelerate the development of tolerance and physical dependence. Users of high-potency products develop tolerance faster, require escalating doses sooner, and experience more severe withdrawal symptoms upon cessation. The pharmacological mechanism is straightforward: flooding CB1 receptors with supraphysiological levels of THC causes rapid downregulation and desensitization of those receptors, driving both tolerance and withdrawal. Users of concentrates and high-potency vapes often report being unable to feel effects from regular flower -- their tolerance has been pushed to a level that only extreme concentrations can overcome.

Anxiety and Panic

High-dose THC exposure is a well-documented trigger for acute anxiety, panic attacks, and paranoid ideation. While low-dose THC may produce anxiolytic effects in some individuals, the dose-response curve for anxiety is biphasic: low doses can reduce anxiety, but high doses reliably increase it. Users of high-potency products are more likely to cross the anxiety-inducing threshold, particularly if they are inexperienced, genetically predisposed to anxiety, or consuming products with inaccurate labeling. For a discussion of THC potency trends, see Cannabis THC Potency.

Sultan's AJPM 2025 Study: Cannabis Product Labeling Accuracy

One of the fundamental assumptions of regulated cannabis markets is that consumers can rely on product labels to make informed decisions about dosing and safety. Dr. Ryan Sultan's research published in the American Journal of Preventive Medicine (AJPM) in 2025 tested this assumption -- and found it wanting.

The labeling problem is not unique to New York City. Studies across multiple state markets have found similar patterns of inaccuracy, particularly in edible products where dosing precision is most critical. When a consumer eats a gummy labeled as containing 10 mg of THC but actually containing 15 mg or 20 mg, the result can be a significantly more intense experience than intended -- with all the attendant risks of high-dose exposure.

For a broader discussion of THC potency trends, see THC Potency.

The Marketing Problem: Candy-Like Products and Youth Appeal

Cannabis edibles are frequently designed and marketed in ways that are virtually indistinguishable from conventional candy and snacks. Gummy bears, sour worms, chocolate bars, cookies, beverages, and cereal-like products dominate the edibles market. While most state regulations prohibit marketing directly to minors, the products themselves are inherently appealing to children and adolescents by virtue of their appearance, flavor, and packaging.

This is not a theoretical concern. The sharp increase in pediatric cannabis exposures reported to poison control centers across the United States is directly linked to children accidentally consuming edible cannabis products that resemble familiar snacks. Between 2017 and 2023, calls to U.S. poison control centers for pediatric cannabis exposures increased by over 1,375% (National Poison Data System). The vast majority of these cases involved edible products.

The parallels to the tobacco industry's historical marketing practices -- flavored products, appealing packaging, youth-oriented branding -- are difficult to ignore. The cannabis industry has argued that these products are marketed to adults, but the gap between marketing intent and real-world impact on youth access and accidental exposure remains a significant public health concern.

Vape device marketing presents similar concerns. Sleek, tech-forward designs, fruit and candy flavors, and social media promotion all contribute to the appeal of cannabis vaping among young people. Instagram and TikTok have become de facto marketing channels for cannabis culture, even as platforms officially prohibit cannabis advertising.

Harm Reduction: If You Are Using High-Potency Products

While abstinence from high-potency cannabis products is the lowest-risk option, harm reduction principles recognize that some individuals will continue to use regardless. The following evidence-based strategies can reduce -- though not eliminate -- the risks associated with high-potency cannabis products.

Regulatory Gaps

The current regulatory framework for cannabis in the United States has significant gaps that directly impact public health and safety. These gaps are the result of a patchwork state-by-state approach to legalization that prioritized tax revenue and criminal justice reform -- worthy goals -- without adequate attention to product safety and public health protections.

Frequently Asked Questions

Related Resources